icon-folder.gif   Conference Reports for NATAP  
 
  17th European AIDS Conference
November 6-9
2019, Basel
Back grey_arrow_rt.gif
 
 
 
Rapid Initiation of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Patients With Human Immunodeficiency Virus (HIV)-1 Infection: Age, Race/Ethnicity, and Gender Subgroup Analyses From the DIAMOND Study
 
 
  17th EACS 2019 Nov 6-9 Basel
Reported by Jules Levin
 
David Anderson,1,* Robert Bolan,2 Edwin DeJesus,3 Jose Guillermo Castro,4 Richard Bruce Simonson,1 Patricia Cosler,1 Sareh Seyedkazemi,1 Donghan Luo,5 Keith Dunn1 1Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 2Los Angeles LGBT Center, Los Angeles, CA, USA; 3Orlando Immunology Center, Orlando, FL, USA; 4University of Miami, Miami, FL, USA; 5Janssen Research & Development, LLC, Titusville, NJ, USA

1114191

1114192

1114193

1114194

1114195

1114196